About us

Company Profile

We are a leading interventional cardiovascular device company in China, located in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies; bioresorbable scaffolds (BRS) and renal denervation (RDN), both addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Our mission is to turn innovation into quality care.

Bioheart leases about 6500 square meters, including 4000 square meters clean workshops and a full-project testing laboratory for related products. Bioheart developed a quality management system which meets the ISO13485/YY0287 standard, and employs or partners with professionals in machinery, materialogy, precision processing, and clinical medicine with extensive experience in product design, quality control, clinical verification, and market development.